ArticleArchives of microbiology2025
miR-7002-5p targets caspase-1 to suppress the inflammatory response of macrophages induced by Streptococcus equi subsp. zooepidemicus.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Streptococcus equi subsp. zooepidemicus (SEZ) is an important zoonotic pathogen that causes severe inflammatory diseases in various animal species. The host inflammatory response is a key factor in SEZ pathogenesis, yet the regulatory role of microRNAs (miRNAs) in this process remains largely unexplored. In this study, we investigated the function of miR-7002-5p in SEZ-induced inflammation using murine macrophage J774A.1 cells and C57BL/6J mice. SEZ infection led to a significant downregulation of miR-7002-5p and upregulation of inflammatory cytokines. Bioinformatics prediction and dual-luciferase reporter assays confirmed that Caspase-1 is a direct target of miR-7002-5p. Overexpression of miR-7002-5p significantly suppressed Caspase-1 activation and reduced the expression of IL-1β, IL-18, IL-6, and TNF-α both in vitro and in vivo. In contrast, inhibition of miR-7002-5p exacerbated inflammatory responses. Furthermore, intranasal delivery of miR-7002-5p mimics in SEZ-infected mice alleviated lung inflammation, as evidenced by reduced cytokine levels and histopathological improvement. These findings suggest that miR-7002-5p mitigates SEZ-induced inflammation by targeting Caspase-1 and may serve as a potential therapeutic target for controlling SEZ infection.
Indexed as
Identifiers
40742551What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.